Clinical trial
Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia
NCT00005935 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00005935 |
|---|---|
| Title | Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia |
| Official title | A Randomized Trial for the Treatment of Relapsing Aplastic Anemia With Mycophenolate Mofetil (MMF) and Cyclosporine (CSA) |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Aplastic Anemia |
| Intervention type | Drug |
| Interventions | Mycophenolate mofetil, Cyclosporine |
| Enrollment | 130 |
| Start date | Jun 1, 2000 |
| Completion | Mar 1, 2002 |
| First posted | Jul 7, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: